Histamine, leukotriene D4 and platelet-activating factor in guinea pig passive cutaneous anaphylaxis.
The involvement of histamine, leukotriene D4 (LTD4) and platelet-activating factor (PAF) in cutaneous anaphylaxis was investigated in a guinea pig model. When given alone, the H1 receptor antagonist chlorpheniramine, the LTD4/E4 antagonist LY171883 and the PAF antagonist WEB2086 were unable to inhibit increased microvascular plasma protein leakage in passive cutaneous anaphylaxis (PCA) reactions, as monitored by the extravasation of intravenously injected 125I-albumin. Furthermore the H2 receptor antagonist cimetidine and the serotonin antagonist methysergide were unable to reduce PCA responses when given alone or in combination with chlorpheniramine. In marked contrast, combinations of antagonists were able to reduce plasma leakage significantly. A combination of chlorpheniramine, LY171883 and WEB2086 virtually abolished plasma leakage during the PCA response, but did not influence the plasma protein leakage induced by intradermal injection of bradykinin. These results demonstrate that these allergic reactions involve several mediators and that the inability of an individual mediator antagonist to reduce responses does not necessarily rule out a role for that mediator.
Weg
V B
VB
Department of Applied Pharmacology, National Heart and Lung Institute, London, U.K.
Watson
M L
ML
Cordeiro
R S
RS
Williams
T J
TJ
D000098:Acetophenones / Q000494:pharmacology; D000818:Animals; D012898:Autacoids / Q000037:antagonists & inhibitors; D001381:Azepines / Q000494:pharmacology; D001798:Blood Proteins / Q000378:metabolism; D001920:Bradykinin / Q000494:pharmacology; D002199:Capillary Permeability / Q000187:drug effects; D002744:Chlorpheniramine / Q000494:pharmacology; D002927:Cimetidine / Q000494:pharmacology; D006168:Guinea Pigs; D006632:Histamine / Q000502:physiology*; D008297:Male; D008784:Methysergide / Q000494:pharmacology; D010323:Passive Cutaneous Anaphylaxis / Q000187:drug effects / Q000502:physiology*; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors / Q000502:physiology*; D013189:SRS-A / Q000502:physiology*; D013777:Tetrazoles / Q000494:pharmacology; D014230:Triazoles / Q000494:pharmacology
D000098:Acetophenones; D012898:Autacoids; D001381:Azepines; D001798:Blood Proteins; D010972:Platelet Activating Factor; D013189:SRS-A; D013777:Tetrazoles; D014230:Triazoles; C052518:WEB 2086; D002744:Chlorpheniramine; D002927:Cimetidine; D006632:Histamine; C044660:LY 171883; D001920:Bradykinin; D008784:Methysergide